2011-66-7Nc1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1ClGRDGBWVSVMLKBV-UHFFFAOYSA-Nhydrolysis product of clonazepam which is used to determine clonazepam in biological products
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 40% (4 of 10) of reports.
Warning
H302 (30%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 10 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses2-Amino-5-nitro-2''-chlorobenzophenone (Clonazepam EP Impurity A) is an impurity of Clonazepam (C587080).
2011-66-7DTXSID20173927